abiraterone,olaparib
astrazeneca,merck
['prostate', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'olaparib', 'propel']
#gu23 here are the awaited final results from #propel trial in crpc #prostatecancer - met its primary endpoint in the itt population: abi + olaparib improves pfs. 
GU Oncologist/Clinical Trials/ Experimental Therapeutics @UCD_Cancer @UCDavisHealth via @uofcincy @GoBEARCATS. Tweets= My opinions #RCC #ASCO #immunotherapy